VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Clinical Trials

<< Previous

Bullboard Posts

Next >>

Comment by G1945Von Mar 06, 2022 6:43am

156 Views

Post# 34487731

RE:Clinical Trials

This trial is sponsored and information for it is provided by Duke University, not Ventripoint.

They are doing this entirely on their own and for their benefit. Let's see what comes of it. Too bad, we need to wait for a year+ to find out if Duke University will endorse it or not.

jmo
G1945V

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec